Year |
Citation |
Score |
2018 |
Oien DB, Moskovitz J. Genetic regulation of longevity and age-associated diseases through the methionine sulfoxide reductase system. Biochimica Et Biophysica Acta. Molecular Basis of Disease. PMID 30481589 DOI: 10.1016/J.Bbadis.2018.11.016 |
0.632 |
|
2018 |
Bastola P, Oien DB, Cooley M, Chien J. Emerging Cancer Therapeutic Targets in Protein Homeostasis. The Aaps Journal. 20: 94. PMID 30151644 DOI: 10.1208/S12248-018-0254-1 |
0.35 |
|
2012 |
Oien DB, Carrasco GA, Moskovitz J. Erratum to “Decreased Phosphorylation and Increased Methionine Oxidation of -Synuclein in the Methionine Sulfoxide Reductase A Knockout Mouse” Journal of Amino Acids. 2012: 1-1. DOI: 10.1155/2012/415713 |
0.627 |
|
2011 |
Oien DB, Carrasco GA, Moskovitz J. Decreased Phosphorylation and Increased Methionine Oxidation of α-Synuclein in the Methionine Sulfoxide Reductase A Knockout Mouse. Journal of Amino Acids. 2011: 721094. PMID 22332004 DOI: 10.4061/2011/721094 |
0.646 |
|
2011 |
Moskovitz J, Maiti P, Lopes DH, Oien DB, Attar A, Liu T, Mittal S, Hayes J, Bitan G. Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo. Biochemistry. 50: 10687-97. PMID 22059533 DOI: 10.1021/Bi201426B |
0.639 |
|
2011 |
Ortiz AN, Oien DB, Moskovitz J, Johnson MA. Quantification of reserve pool dopamine in methionine sulfoxide reductase A null mice. Neuroscience. 177: 223-9. PMID 21219974 DOI: 10.1016/J.Neuroscience.2011.01.001 |
0.633 |
|
2010 |
Oien DB, Ortiz AN, Rittel AG, Dobrowsky RT, Johnson MA, Levant B, Fowler SC, Moskovitz J. Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse. Journal of Neurochemistry. 114: 51-61. PMID 20374422 DOI: 10.1111/J.1471-4159.2010.06721.X |
0.631 |
|
2010 |
Oien DB, Osterhaus GL, Lundquist BL, Fowler SC, Moskovitz J. Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse. Neuroscience Letters. 468: 38-41. PMID 19854239 DOI: 10.1016/J.Neulet.2009.10.058 |
0.685 |
|
2010 |
Moskovitz J, Oien DB. Protein carbonyl and the methionine sulfoxide reductase system. Antioxidants & Redox Signaling. 12: 405-15. PMID 19686038 DOI: 10.1089/Ars.2009.2809 |
0.676 |
|
2009 |
Oien DB, Shinogle HE, Moore DS, Moskovitz J. Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. Journal of Molecular Neuroscience : Mn. 39: 323-32. PMID 19653131 DOI: 10.1007/S12031-009-9274-8 |
0.605 |
|
2009 |
Oien DB, Moskovitz J. Selenium and the methionine sulfoxide reductase system. Molecules (Basel, Switzerland). 14: 2337-44. PMID 19633607 DOI: 10.3390/Molecules14072337 |
0.652 |
|
2009 |
Oien DB, Canello T, Gabizon R, Gasset M, Lundquist BL, Burns JM, Moskovitz J. Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies. Archives of Biochemistry and Biophysics. 485: 35-40. PMID 19388147 DOI: 10.1016/J.Abb.2009.01.020 |
0.652 |
|
2008 |
Oien DB, Osterhaus GL, Latif SA, Pinkston JW, Fulks J, Johnson M, Fowler SC, Moskovitz J. MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radical Biology & Medicine. 45: 193-200. PMID 18466776 DOI: 10.1016/J.Freeradbiomed.2008.04.003 |
0.68 |
|
2008 |
Oien DB, Moskovitz J. Substrates of the methionine sulfoxide reductase system and their physiological relevance. Current Topics in Developmental Biology. 80: 93-133. PMID 17950373 DOI: 10.1016/S0070-2153(07)80003-2 |
0.655 |
|
2008 |
Oien D, Wang X, Moskovitz J. Genomic and Proteomic Analyses of the Methionine Sulfoxide Reductase A Knockout Mouse Current Proteomics. 5: 96-103. DOI: 10.2174/157016408784911891 |
0.577 |
|
2007 |
Pal R, Oien DB, Ersen FY, Moskovitz J. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Experimental Brain Research. 180: 765-74. PMID 17333008 DOI: 10.1007/S00221-007-0903-6 |
0.677 |
|
2007 |
Oien DB, Moskovitz J. Ablation of the mammalian methionine sulfoxide reductase A affects the expression level of cysteine deoxygenase. Biochemical and Biophysical Research Communications. 352: 556-9. PMID 17126812 DOI: 10.1016/J.Bbrc.2006.11.063 |
0.661 |
|
2006 |
Oien D, Moskovitz J. Protein-carbonyl accumulation in the non-replicative senescence of the methionine sulfoxide reductase A (msrA) knockout yeast strain. Amino Acids. 32: 603-6. PMID 17077964 DOI: 10.1007/S00726-006-0448-1 |
0.632 |
|
Low-probability matches (unlikely to be authored by this person) |
2018 |
Oien DB, Garay T, Eckstein S, Chien J. Abstract 2448: Chemotherapy drug-induced AXL activation and cell survival signaling via reactive oxygen species that can be inhibited to enhance drug efficacy in mesothelioma Cancer Research. 78: 2448-2448. DOI: 10.1158/1538-7445.Am2018-2448 |
0.291 |
|
2017 |
Oien DB, Garay T, Eckstein S, Chien J. Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy. Frontiers in Pharmacology. 8: 970. PMID 29375377 DOI: 10.3389/Fphar.2017.00970 |
0.275 |
|
2019 |
Kumar S, Oien DB, Khurana A, Cliby W, Hartmann L, Chien J, Shridhar V. Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer. Frontiers in Oncology. 9: 986. PMID 31632917 DOI: 10.3389/Fonc.2019.00986 |
0.272 |
|
2019 |
Oien DB, Pathoulas CL, Ray U, Thirusangu P, Kalogera E, Shridhar V. Repurposing Quinacrine for Treatment-Refractory Cancer. Seminars in Cancer Biology. PMID 31562955 DOI: 10.1016/J.Semcancer.2019.09.021 |
0.248 |
|
2016 |
Oien DB, Chien J, Cheng N. Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway. Translational Cancer Research. 5: S514-S519. PMID 30542639 DOI: 10.21037/Tcr.2016.09.32 |
0.246 |
|
2016 |
Oien DB, Chien J. TP53 mutations as a biomarker for high-grade serous ovarian cancer: are we there yet? Translational Cancer Research. 5. DOI: 10.21037/8807 |
0.206 |
|
2021 |
Oien DB, Ray U, Pathoulas CL, Jin L, Thirusangu P, Jung D, Kumka JE, Xiao Y, Sarkar Bhattacharya S, Montoya D, Chien J, Shridhar V. Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines. Cancers. 13. PMID 34572872 DOI: 10.3390/cancers13184645 |
0.181 |
|
2022 |
Thirusangu P, Ray U, Sarkar Bhattacharya S, Oien DB, Jin L, Staub J, Kannan N, Molina JR, Shridhar V. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma. Oncogene. PMID 35804016 DOI: 10.1038/s41388-022-02391-x |
0.126 |
|
2023 |
Oien DB, Sharma S, Hattersley MM, DuPont MM, Criscione SW, Prickett LB, Goeppert AU, Drew L, Yao Y, Zhang J, Chan HM. BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5. Blood Advances. PMID 37184294 DOI: 10.1182/bloodadvances.2022009257 |
0.12 |
|
2021 |
Oien DB, Sarkar Bhattacharya S, Chien J, Molina J, Shridhar V. Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations. Frontiers in Pharmacology. 12: 750352. PMID 34621176 DOI: 10.3389/fphar.2021.750352 |
0.098 |
|
2022 |
Criscione SW, Martin MJ, Oien DB, Gorthi A, Miragaia RJ, Zhang J, Chen H, Karl DL, Mendler K, Markovets A, Gagrica S, Delpuech O, Dry JR, Grondine M, Hattersley MM, et al. The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells. Npj Precision Oncology. 6: 95. PMID 36575215 DOI: 10.1038/s41698-022-00337-w |
0.083 |
|
2022 |
Thirusangu P, Ray U, Sarkar Bhattacharya S, Oien DB, Jin L, Staub J, Kannan N, Molina JR, Shridhar V. Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma. Oncogene. PMID 36443398 DOI: 10.1038/s41388-022-02470-z |
0.057 |
|
Hide low-probability matches. |